KDev Investments AB 13D and 13G filings for Aprea Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-16 06:51 am Sale |
2020-12-31 | 13G | Aprea Therapeutics, Inc. APRE |
KDev Investments AB | 89,035 8.400% |
-33,207 (-27.17%) |
Filing |